x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAB-0012961
| Product Information | |
|---|---|
| Clonality | Polyclonal |
| Host Species | Rabbit |
| Reactivity | Human |
| Applications | WB |
| Product Description | Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu560 of human xanthine dehydrogenase/oxidase protein. Antibodies are purified by peptide affinity chromatography. |
| Format | Liquid |
| Purity | Affinity purity |
| Target Information | |
|---|---|
| Target Name | XDH |
| UniProt No. | P47989 |
| Gene ID | 7498 |
| Gene Description | Xanthine dehydrogenase/oxidase is a rate-limiting enzyme in purine degradation. It catalyzes the oxidation of hypoxanthine to xanthine and the oxidation of xanthine to uric acid. The circadian rhythm of the expression of this enzyme and its enzymatic activity lead to circadian oscillation of uric acid concentrations in the liver and blood. In macrophages, the histone methyltransferase Setdb2 mediates the elevated expression of xanthine dehydrogenase/oxidase, and consequently, the increased production of uric acid. Pharmacological targeting of the uric acid pathway of purine degradation improves wound healing. In addition, research studies show that the xanthine oxidase activity of this enzyme contributes to the reactive oxygen species generation in macrophages and is essential in innate inflammatory signaling. |
| Shipping & Storage | |
|---|---|
| Shipping | Shipped at 4 °C. |
| Storage Instructions | Store at –20 °C. Do not aliquot the antibody. |
| Storage Buffer | Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, and 50% glycerol. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
